OptiChroniX
Sch├╢nenbuch
About OptiChroniX
OptiChroniX is a Swiss Digital Health Solution company dedicated to improving brain health early. We strive to optimize lifestyle and make medicine smart, so as to improve clinical outcomes, quality of life, cost-effectiveness, and budget impact of clinical treatment. At OptiChroniX, we develop digital health interventions at the intersection of biomedical, behavioral, computing, and engineering research, deployed on smartphones to personalize and track a patient’s health progress by collecting data from other wearables and nearables. The informed choices offered aim to provide tailored coaching in order to improve health literacy and medication adherence and to positively impact modifiable risk factors primarily responsible for the cognitive decline in patients affected by Alzheimer’s disease and associated co-morbidities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $460.4K
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2023)
- Website: optichronix.com
- Phone: +41799024330
Industries & Categories
Health Care, Medical Device, mHealth, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/optichronix-180570 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.